U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07048860) titled 'ICOPE INTENSE-K Pilot Study' on Dec. 19, 2024.
Brief Summary: ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Ageing
Intervention:
OTHER...